INTAL Drug Patent Profile
✉ Email this page to a colleague
When do Intal patents expire, and when can generic versions of Intal launch?
Intal is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in three NDAs.
The generic ingredient in INTAL is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Intal
A generic version of INTAL was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
Summary for INTAL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 4,211 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INTAL at DailyMed |
US Patents and Regulatory Information for INTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms Llc | INTAL | cromolyn sodium | AEROSOL, METERED;INHALATION | 018887-001 | Dec 5, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
King Pharms Llc | INTAL | cromolyn sodium | AEROSOL, METERED;INHALATION | 018887-001 | Dec 5, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for INTAL
See the table below for patents covering INTAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1918142 | ⤷ Try a Trial | |
Japan | S5341662 | ⤷ Try a Trial | |
Japan | S5435209 | DISPERSION OR SUSPENSION OF LECITHIN * SORBITANE OR SORBITOL ESTER | ⤷ Try a Trial |
Netherlands | 7206251 | ⤷ Try a Trial | |
Denmark | 134646 | ⤷ Try a Trial | |
Japan | S5294411 | DISODIUM CHROMOGLYCATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |